Fig. 6.
Fig. 6. The effect of cell dose on engraftment of B6.SJL marrow cells into 100-cGy–irradiated BALB/c mice subjected to spleen cell pre-exposure and CD40 ligand blockade. / BALB/c hosts irradiated with 100 cGy were infused with varying levels of B6.SJL marrow cells after splenic presensitization (day −10, 10 million cells) and CD40 ligand antibody blockade (days −10, −7, −3, 0, and +3). Results are expressed as percentage (%) engraftment (CD45.1+ cells) ± 1 SEM from 3 to 15 weeks after transplantation. There were 5 mice per group. There was a significant trend toward increasing engraftment as the cell doses increased; for weeks 3, 6, 9, 12, and 15 weeks P values were .01, .02, .12, .03, and .03, respectively, although when analyzed independently with Wilcoxon rank order there was no significant difference between the 80 and 120 million cell groups.

The effect of cell dose on engraftment of B6.SJL marrow cells into 100-cGy–irradiated BALB/c mice subjected to spleen cell pre-exposure and CD40 ligand blockade.

BALB/c hosts irradiated with 100 cGy were infused with varying levels of B6.SJL marrow cells after splenic presensitization (day −10, 10 million cells) and CD40 ligand antibody blockade (days −10, −7, −3, 0, and +3). Results are expressed as percentage (%) engraftment (CD45.1+ cells) ± 1 SEM from 3 to 15 weeks after transplantation. There were 5 mice per group. There was a significant trend toward increasing engraftment as the cell doses increased; for weeks 3, 6, 9, 12, and 15 weeks P values were .01, .02, .12, .03, and .03, respectively, although when analyzed independently with Wilcoxon rank order there was no significant difference between the 80 and 120 million cell groups.

Close Modal

or Create an Account

Close Modal
Close Modal